- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 265/36 - 1,4-OxazinesHydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
Patent holdings for IPC class C07D 265/36
Total number of patents in this class: 473
10-year publication summary
|
36
|
28
|
28
|
32
|
30
|
20
|
15
|
28
|
24
|
18
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| BASF SE | 20940 |
16 |
| BP Oil International Limited | 77 |
15 |
| Merck Sharp & Dohme LLC | 3751 |
14 |
| Abbvie Inc. | 1800 |
12 |
| Boehringer Ingelheim International GmbH | 4642 |
10 |
| Takeda Pharmaceutical Company Limited | 2708 |
8 |
| Shionogi & Co., Ltd. | 852 |
8 |
| Calico Life Sciences LLC | 96 |
8 |
| The Regents of the University of California | 19961 |
7 |
| Albert Einstein College of Medicine, Inc. | 576 |
7 |
| Mitsubishi Tanabe Pharma Corporation | 582 |
7 |
| Reviva Pharmaceuticals, Inc. | 45 |
7 |
| F. Hoffmann-La Roche AG | 7947 |
6 |
| AbbVie Deutschland GmbH & Co. KG | 261 |
6 |
| Arcus Biosciences, Inc. | 139 |
6 |
| Enko Chem, Inc. | 16 |
6 |
| AstraZeneca AB | 2892 |
5 |
| Sumitomo Chemical Company, Limited | 9043 |
5 |
| Dana-Farber Cancer Institute, Inc. | 2573 |
5 |
| Lycera Corporation | 31 |
5 |
| Other owners | 310 |